However, low expression of LATS2 may be related to other mechanisms than the hypermethylation of its promoter, as observed by Peng et al. Conversely, they observed that low expression of LATS2 is associated with worse prognosis in CRC. This evidence concerns the gene LATS2 and colorectal carcinoma.